India is a marketplace booming with smartphones duking it out on various price points. From the killer-budget phones to the ultra-flagships, there is a phone for everyone. Of course, the market ...
Within Novo Nordisk's comprehensive business update to investors, attention latched onto early data for an oral obesity therapy that outperformed the company’s big-selling GLP-1 agonist Wegovy ...